JLL completed a sublease for growing U.K.-based biotech company Ochre Bio at 430 E. 29th St. within the Alexandria Center for Life Science – New York City. Backed by a $1-billion funding partnership with Boehringer Ingelheim, the liver research firm will relocate from the BioLabs incubator at 180 Varick St. to occupy 5,894 square feet of lab and office space on the sixth floor of the West Tower at the Alexandria Center.
The Alexandria Center will house Ochre’s late-stage validation facilities, the largest ex-vivo machine perfusion laboratory of human donor livers in the world, where the company’s novel RNA therapies will be validated prior to entering clinical trials.
A JLL team including EVP Bill Harvey, SVP John Cahill and associate VP Thomas Burrus represented both Ochre Bio and the unnamed sublandlord. The deal is the second relocation from BioLabs the team has arranged in recent months. In December 2024, they represented next-generation drug discovery platform Waypoint Bio in its lease at Alexandria.
The post U.K. Biotech Firm Relocates Lab and Office Space to Alexandria Center appeared first on Connect CRE.
​Â